What is your China strategy?
China: the future of pharma, photo by beardnan
Oh, if I had a dollar for every time I heard about the rise of China as the hottest new market in everything. What is quite possibly the most hyped, covered and documented economic trend certainly doesn’t need much more to bring attention to it.
However, I still found this report interesting in that it brings some actual numbers and predictions with respect to the pharma industry. Research and Market’s report, “China’s Pharmaceutical Industry – Porter’s Five Forces Strategy Analysis” predicts that China will become the fifth-largest pharma market by 2010, and the largest by 2050.
Obviously challenges remain:
“Investors continue to face a range of obstacles, many of which stem from the legacy of central planning of the industry. These include complex distribution, under-developed retail options, intellectual property infringements and pricing controls and pressures. At the same time, the continuing reliance of leading domestic companies on generic drugs has prevented the emergence of Chinese brands.”
So, seriously, what is your China strategy?
Kevin currently manages initial client engagements with the MaRS Venture Group. He also administers a federal fund that provides mentorship to start-up companies across Ontario.